DRUG · Unmapped registry intervention
10 mg TZP-102
Find medicine records ·
Find other trials using this name
Clinical trial
Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
NCT01664637
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedDiabetic Gastroparesis Efficacy/Safety Study of TZP-102
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetic Gastroparesisunresolved
Interventions
10 mg TZP-102DRUG
PlaceboDRUG
Sponsors & collaborators
Tranzyme, Inc.lead sponsor
Mapped research locations
MiamiFlorida, United States2BialystokPoland2LublinPoland2BostonMassachusetts, United States1PortlandOregon, United States1IndianapolisIndiana, United States1JacksonvilleFlorida, United States1Oklahoma CityOklahoma, United States1WarsawPoland1TucsonArizona, United States1Winston-SalemNorth Carolina, United States1Long BeachCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01664637 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.